| Health / Medical Topics |
Lactobacillus brevis CD2 Lozenge
A lozenge containing an extract from the Lactobacillus brevis (L. brevis) with potential anti-inflammatory activity. As L. brevis CD2 contains high levels of arginine deiminase, which catalyzes the conversion of arginine to citrulline and ammonia, administration of this lozenge leads to hydrolysis of arginine in the oral cavity. The growth of bacteria, which depends on arginine, is halted, polyamine biosynthesis is reduced and the production of nitric oxide (NO) is reduced. The reduction in NO generation may further prevent inflammation in the oral cavity. Therefore, this agent may be able to reduce chemo- and radiotherapy-induced mucositis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A species of facultatively anaerobic/microaerophilic, Gram positive, rod shaped bacteria in the phylum Firmicutes. This species is nonmotile, ferments D ribose, galactose,…
A nutritional supplement containing probiotic cultures of Lactobacillus acidophilus (L. acidophilus), L. rhamnosus Streptococcus thermophilus, Bifidobacterium lactis, (B. lactis), B. longum and…
A vaginal tablet containing a low dose of the estrogen hormone estriol and lyophilized lactobacillus acidophilus, with hormone replacement and vaginal flora…
A species of facultatively anaerobic, Gram positive, rod shaped bacteria in the phylum Firmicutes. This species is nonmotile, homofermentative, indole negative, produces…
A type of bacterium that makes lactic acid (a substance that is made from sugars found in milk and is also made…
A taxonomic family of bacterium that ferment carbohydrates into lactic acid, in the phylum Firmicutes that includes the genera Lactobacillus and Pediococcus,…
